Literature DB >> 22535665

CD1d expression on and regulation of murine hematopoietic stem and progenitor cells.

Hal E Broxmeyer1, Kent Christopherson, Giao Hangoc, Scott Cooper, Charlie Mantel, Gourapura J Renukaradhya, Randy R Brutkiewicz.   

Abstract

In the present study, surface CD1d, which is involved in immune cell interactions, was assessed for effects on hematopoiesis. Mouse BM hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) express CD1d. The numbers and cycling status of HPCs in the BM and spleen of different strains of cd1d(-/-) mice were enhanced significantly, suggesting that CD1d is a negative regulator of HPCs. In support of this, CD1d was required for the SCF and Flt3 ligand synergistic enhancement of CSF induction of HPC colony formation and for HPC response to myelosuppressive chemokines. Colony formation by immature subsets of HPCs was greatly enhanced when normal, but not cd1d(-/-), BM cells were pretreated with CD1d Abs in vitro. These effects required the full CD1d cytoplasmic tail. In contrast, long-term, but not short-term, repopulating HSC engraftment was impaired significantly, an effect that was minimally influenced by the presence of a truncated CD1d cytoplasmic tail. Pretreatment of normal BM cells with CD1d Abs greatly enhanced their engraftment of HSCs. The results of the present study implicate CD1d in a previously unrecognized regulatory role of normal and stressed hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535665      PMCID: PMC3382932          DOI: 10.1182/blood-2012-01-404012

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling.

Authors:  S P Colgan; R M Hershberg; G T Furuta; R S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.

Authors:  Ya-Hui Chiu; Se-Ho Park; Kamel Benlagha; Claire Forestier; Jayanthi Jayawardena-Wolf; Paul B Savage; Luc Teyton; Albert Bendelac
Journal:  Nat Immunol       Date:  2001-12-03       Impact factor: 25.606

3.  CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain.

Authors:  J Jayawardena-Wolf; K Benlagha; Y H Chiu; R Mehr; A Bendelac
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

4.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells.

Authors:  Hal E Broxmeyer; David S Franklin; Scott Cooper; Giao Hangoc; Charlie Mantel
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

Review 6.  The unconventional lifestyle of NKT cells.

Authors:  Mitchell Kronenberg; Laurent Gapin
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

Review 7.  Natural killer T (NKT) cells and their role in antitumor immunity.

Authors:  Randy R Brutkiewicz; Venkataraman Sriram
Journal:  Crit Rev Oncol Hematol       Date:  2002-03       Impact factor: 6.312

8.  Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells.

Authors:  Tonya J Roberts; Venkataraman Sriram; Philip M Spence; Ming Gui; Kyoko Hayakawa; Igor Bacik; Jack R Bennink; Jonathan W Yewdell; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

9.  Immune responses in 4-1BB (CD137)-deficient mice.

Authors:  Byoung S Kwon; Jose C Hurtado; Zang H Lee; Kyu B Kwack; Su K Seo; Beom K Choi; Beverly H Koller; Godwin Wolisi; Hal E Broxmeyer; Dass S Vinay
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

10.  Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M.

Authors:  Hal E Broxmeyer; Heather A Bruns; Shangming Zhang; Scott Cooper; Giao Hangoc; Andrew N J McKenzie; Alexander L Dent; Ulrike Schindler; Lisa K Naeger; Timothy Hoey; Mark H Kaplan
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

View more
  5 in total

1.  Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.

Authors:  Vrajesh V Parekh; Lan Wu; Danyvid Olivares-Villagómez; Keith T Wilson; Luc Van Kaer
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

2.  Chromatin remodeling subunit BRM and valine regulate hematopoietic stem/progenitor cell function and self-renewal via intrinsic and extrinsic effects.

Authors:  Samisubbu R Naidu; Maegan Capitano; James Ropa; Scott Cooper; Xinxin Huang; Hal E Broxmeyer
Journal:  Leukemia       Date:  2021-10-01       Impact factor: 12.883

3.  Expression of NR5A2, NUP153, HNF4A, USP15 and FNDC3B is consistent with their use as novel biomarkers for bovine mammary stem/progenitor cells.

Authors:  Ratan K Choudhary; Anthony V Capuco
Journal:  J Mol Histol       Date:  2021-01-05       Impact factor: 2.611

4.  Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.

Authors:  Haneen Nur; Karel Fostier; Sandrine Aspeslagh; Wim Renmans; Elisabeth Bertrand; Xavier Leleu; Mérédis Favreau; Karine Breckpot; Rik Schots; Marc De Waele; Els Van Valckenborgh; Elke De Bruyne; Thierry Facon; Dirk Elewaut; Karin Vanderkerken; Eline Menu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

5.  Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.

Authors:  Basavaraj Binjawadagi; Varun Dwivedi; Cordelia Manickam; Kang Ouyang; Yun Wu; Ly James Lee; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2014-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.